Receiving a non-compliance letter from the NYSE is a significant regulatory event that typically leads to negative investor sentiment. The direct mention of the trading price issue points to a risk of further decline if not addressed promptly. This situation could lead to short-term volatility and downward pressure on Zepp Health's stock price as investors may react negatively to the news of potential compliance issues.